noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Bureau of Land Management -[...]

BLM announces seasonal fire restrictions in NE California, NW Nevada
Shelley Moore Capito

EPW Committee Passes Bipartisan Water Resources Development Act of 2026
City of Fairfield, CA

35th Annual Fairfield Tomato & Vine Festival returns August 15-16

Healthcare

Ensysce Biosciences Inc.

07/15/2026 | Press release | Distributed by Public on 07/15/2026 14:16

Management Change/Compensation (Form 8-K)

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On July 10, 2026, Ensysce Biosciences Inc. (the "Company") received a resignation notice, dated and effective July 10, 2026, from Jeffrey Millard, who served as our Chief Operating Officer.

Ensysce Biosciences Inc. published this content on July 15, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 15, 2026 at 20:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]